CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,577,126
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-21 | Selby Brian L. VP, Finance | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2020-12-18 | CONWAY ROBERT E Director | Purchase | +10,000 | $4.16 | $42K | 30,000 |
| 2020-09-25 | CONWAY ROBERT E Director | Purchase | +5,000 | $4.28 | $21K | 20,000 |
| 2020-09-22 | CONWAY ROBERT E Director | Purchase | +3,056 | $4.66 | $14K | 15,000 |
| 2020-09-21 | CONWAY ROBERT E Director | Purchase | +10,000 | $4.77 | $48K | 11,944 |
| 2018-04-03 | Keuer Thomas A Chief Operating Officer | Sale | −482 | $0.50 | $242 | 13,153 |
| 2018-04-02 | Selby Brian L. VP, Finance | Sale | −1,114 | $0.50 | $556 | 0 |
| 2018-03-01 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-03-01 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-03-01 | Grais Linda S Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-03-01 | MITCHELL DANIEL J Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-03-01 | Hove Anders D Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-02-28 | Keuer Thomas A Chief Operating Officer | Sale | −410 | $0.72 | $294 | 13,635 |
| 2018-02-27 | Selby Brian L. VP, Finance | Sale | −161 | $0.53 | $85 | 1,114 |
| 2018-02-27 | VENROCK HEALTHCARE CAPITAL PARTNERS LP 10% owner | Sale | −41,331 | $0.53 | $22K | 0 |
| 2018-02-26 | VENROCK HEALTHCARE CAPITAL PARTNERS LP 10% owner | Sale | −1,500,000 | $0.55 | $825K | 41,331 |
| 2018-02-26 | Viswanathan Ravi 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | Sonsini Peter W. 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | SANDELL SCOTT D 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | Sakoda Jon 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
Page 20 of 24 · 473 trades